Norovirus Bivalent-Vaccine Efficacy Study

NCT01609257 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

132

Enrollment

INDUSTRY

Sponsor class

Conditions

Prevention From Norovirus Infection

Interventions

BIOLOGICAL: Norovirus Bivalent Vaccine
BIOLOGICAL: Saline Comparator

Sponsor

Takeda